Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-270-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 840 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The UVCB substance to be registered is a mixture of the two Guerbet alcohols 2 -hexyldecan-1-ol & 2-octyldodecan-1 -ol and their corresponding esters with C12 and C14 fatty acids. Repeated dose toxicity studies are not available for the UVCB substance. The potential to induce hazard after repeated exposure is evaluated on the basis of experimental data for Guerbet alcohols and esters of branched alcohols with fatty acids.
Of these two substance classes present in the UVCB substance, the Guerbet alcohols are considered to have the higher impact on the toxicological evaluation, for the following reasons:
- The two Guerbet alcohols are the major components in the UVCB substance, accounting for appr. 30-50%
- The ester components are expected to be metabolized to fatty acids and the two free Guerbet alcohols, thus contributing to the fraction of Guerbet alcohols
- In comparison to the Guerbet alcohol esters, the free Guerbet alcohols have a lower molecular weight, which would favor their uptake
- Having a free functional group, the Guerbet alcohols are more prone to undergo physiological reactions
With regard to the Guerbet alcohols in the UVCB, a well documented 13 week subchronic toxicity study is available for 2-octyldodecan-1-ol (C20 Guerbet alcohol). Male and female rats received the sustance daily by gavage. There were no indications that 2-octyldodecan-1-ol was toxic at the limit dose of 1 ml/kg bw/d (or 840 mg/kg bw, assuming test substance density of 0.84 g/cm3).Due to their structural similarity no effects are expected after repeated oral application of 2 -hexyldecan-1-ol either.
Concerning the esters of 2 -hexyldecan-1-ol & 2-octyldodecan-1 -ol with C12 and C14 fatty acids, no study was available for the specific components as such. Taking into account toxicokinetic aspects, it can be expected that the esters are cleaved in the body to the corresponding Guerbet alcohols and fatty acids. For the Guerbet alcohols, a study with 2-octyldodecan-1-ol hasalready been discussed in this chapter. The other type of cleavage products, C12 and C14 fatty acids, is identical with nutrient fatty acids contained in the daily diet. Therefore, a toxic impact is not assumed.
A part of the esters contained in the UVCB substance might not undergo a metabolic cleavage and could theoretically be absorbed after micellular solubilisation. Therefore, repeated dose toxicity data for esters of branched alcohols with fatty acids were also taken into account. A repeated dose toxicity study is available for the reaction product of 2-ethylhexanol with C8-16 fatty acids. This compound is a close homologue to the esters in the UVCB substance, with a very similar fatty acid pattern, but an alcoholic structure which differs in the chain length (close homologue: C8 branched alcohol, esters in the UVCB substance: C16 or C20 branched alcohol). Due to these minor structural variations, the data for the close homologue can be considered for the evaluation of the skin sensitization potential of the ester components in the UVCB substance.
In a 28-day study with the close homologue, areaction product of 2-ethylhexanol with C8-16 fatty acids,a NOAEL of1000 mg/kg was found based on the lack of toxicity in clinical, neurological, hematological and biochemical examinations as well as necropsy observations, organ weights, body weights, food consumption and histopathological findings.
The UVCB substance to be registered has a low vapour pressure of <= 2.3*10-7 atm ( <= 2.3*10-2 Pa; <= 2.3*1o-4 mbar) at 20 °C) and a relatively high boiling point (>= 344 °C), indicating that inhalation as a vapour will be negligible. If the UVCB substance reaches the respiratory tract, passive diffusion is unlikely due to the high log Pow, the low water solubility the relatively high molecular weight. Theoretically, a systemic uptake could take place after micellular solubilisation. However, the oral route seems to be more appropriate for evaluating the repeated dose toxicity, as a higher bioavailability can be assumed.
Due to the expected low dermal uptake and the resulting lower bioavailability, the oral route represents a worst case compared to the dermal route. Consequently, the actual dermal LD50 can be assumed to be in the range of the oral LD50 or even higher.
In conclusion, no hazard was identified for the compounds in the UVCB substance with regard to repeated dose toxicity.Justification for selection of repeated dose toxicity via oral route - systemic effects endpoint:
- Acceptable, well documented report.
- Study with longest study duration.
- Substance is most representative for the UVCB
Justification for classification or non-classification
Available data are conclusive but not sufficient for classfication with regard to repeated dose toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.